CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,551 | -91.4% | 247 | -85.9% | 0.00% | – |
Q3 2022 | $18,000 | +100.0% | 1,747 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | -99.1% | 1,747 | -98.4% | 0.00% | -100.0% |
Q1 2022 | $987,000 | +5705.9% | 107,519 | +9674.5% | 0.01% | – |
Q4 2021 | $17,000 | -93.1% | 1,100 | -89.4% | 0.00% | -100.0% |
Q3 2021 | $248,000 | – | 10,397 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 674,196 | $10,174,000 | 6.39% |
72 Investment Holdings, LLC | 474,067 | $7,154,000 | 6.35% |
Velan Capital Investment Management LP | 210,695 | $3,179,000 | 2.47% |
PFM Health Sciences, LP | 4,092,309 | $59,418,000 | 2.02% |
Monashee Investment Management LLC | 504,377 | $7,611,000 | 1.88% |
CloudAlpha Capital Management Limited/Hong Kong | 415,000 | $6,262,000 | 1.49% |
Avidity Partners Management LP | 2,674,067 | $40,352,000 | 0.86% |
Rokos Capital Management LLP | 570,359 | $8,604,000 | 0.52% |
Green Alpha Advisors, LLC | 35,592 | $537,000 | 0.36% |
Tekla Capital Management LLC | 699,377 | $9,875,000 | 0.32% |